NEUROENDOCRINE TUMOUR OF THE RECTUM

NEUROENDOCRINE TUMOUR OF THE RECTUM was reported 32 times

NEUROENDOCRINE TUMOUR OF THE RECTUM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
1 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 11 0.0000
3 Leukocyte Growth Factor [EPC] 2 0.0000
4 Mood Stabilizer [EPC] 1 0.0000
5 Anti-epileptic Agent [EPC] 1 0.0000
6 GLP-1 Receptor Agonist [EPC] 2 0.0000